Ono Pharmaceutical acquires Deciphera for $2.4B after biotech’s Phase 3 win
Japanese drugmaker Ono Pharmaceutical is acquiring cancer-focused biotech Deciphera Pharmaceuticals for $2.4 billion, the companies announced Monday morning. The deal will see Ono acquire all outstanding Deciphera stock at a price of $25.60 per share, representing about a 75% premium over its Friday closing price of $14.65. It’s expected to